Dermatologic Considerations During Cancer Therapy

Treatment-related dermatologic toxicities are reported in as many as 90% of patients with cancer and can be among the most distressing adverse events, causing emotional turmoil in addition to physical symptoms. When severe, dermatologic toxicities may lead to dose modification or discontinuation, and failure to identify and treat these myriad events often leads to noncompliance or inconsistent administration of anti-cancer treatments, all of which result in sub-optimal disease outcomes for patients.

Join Megan Bielawa, DMSc, MS, PA-C, and Cara Norelli, MS, AGNP-C, both of Memorial Sloan Kettering Cancer Center, as they provide visual examples of numerous treatment-related adverse events include lichenoid drug eruptions, bullous pemphigoid, and both acute and chronic radiation dermatitis. Dermatologic emergencies such as acute generalized exanthematous pustulosis (AGEP), drug-induced hypersensitivity syndrome (formerly DRESS), and Stevens-Johnson Syndrome also are covered. Additional topics discussed include recommendations for grading dermatologic adverse events (according to the Common Terminology Criteria for Adverse Events [CTCAE], version 5.0), explanations of the pros and cons of the different therapeutic vehicles used in dermatology, and topical corticosteroid potency groupings and associated agents.

Funding and support provided by Amgen and Johnson & Johnson

New Bonus Resources Added!

Dermatologic Issues Associated with Cancer Therapy

Quick Facts Guide



 
 
Dermatologic Issues Associated With Cancer and Cancer Therapy

Dermatologic Issues Associated With Cancer and Cancer Therapy

Download
Identifying and Managing Dermatologic Toxicities Associated With Cancer and Cancer Therapy: A Brief Clinical Resource

Identifying and Managing Dermatologic Toxicities Associated With Cancer and Cancer Therapy: A Brief Clinical Resource

Download



Meet The Faculty


Megan Bielawa, DMSc, MS, PA-C
Megan Bielawa is a board-certified physician assistant specializing in dermatology. She has been working in the field of dermatology for 6 years and specifically in oncodermatology for the past 4 years at Memorial Sloan Kettering Cancer Center. She serves as a guest lecturer for the Hofstra University Physician Studies program where she developed the Dermatology for Patients of Color curriculum. She also serves as a mentor and clinical preceptor for PA students.
Cara Norelli, MS, AGNP-C
Cara Norelli is a board-certified adult nurse practitioner with 7 years of dermatology experience and is currently specializing in oncodermatology at Memorial Sloan Kettering Cancer Center. Ms. Norelli is a member of the Oncology Nursing Society (ONS), and she was a 2021 recipient of the ONS Pearl Moore "Making a Difference" Award.